Exact Sciences (EXAS) stock catapulted Wednesday on a Bloomberg report that Abbott Laboratories (ABT) is nearing a deal to buy the cancer-finding specialist. In afternoon trades, Exact shares surged 18.8% to 82.75, while Abbot stock sank 3.9% to 124.97. The rally pushed Exact Sciences stock into a breakout. Shares top a buy point at 72.83 out of a cup base,…
